ED50 of Esketamine for Laser Treatment in Children

About This Study

There is limited research on the combined use of esketamine and alfentanil for anesthesia during facial laser treatment in pediatric patients, and the effective dosage of esketamine for inhibiting body movement remains unclear. We explore the effective dose of esketamine combined with alfentanil for the inhibition of body movement during facial laser treatment in pediatric patients.

Conditions Studied

Interventions

• •Esketamine

Eligibility

Inclusion Criteria:

* age between 3 years and 12 years old
* patients scheduled for laser treatment of facial lesion

Exclusion Criteria:

* patients with airway infection during the last 1 month
* patients with cardiac or pulmonary disorder
* patients with hepatic or renal disfunction
* patients with neurologic or psychiatric disorder